Demo brand · Claims Verified

Your warning letter

Demo brand, Inc. · Unapproved New Drugs/Misbranded · dated Oct 28, 2026

9working days left · due Nov 18

8Quoted claims ruled

6Critical

1Same claim found in your other copy

FDA asks for a written response within 15 working days. The count runs from the letter’s date. If you received it later, count from the day it arrived. Your counsel files the response.

Every claim the letter quotes, with the corrective action

Critical

“DemoNerve Nerve Support, 60 capsules: delivers key nutrients to damaged and inflamed nerves.”

The product title itself promises help for damaged and inflamed nerves, so every place the title runs carries a treatment claim.

→ Rename the product title, since the title itself makes the treatment claim.

Standard: Product name implying treatment

Critical

“Formulated for damaged and inflamed nerves.”

Describing nerves as damaged and inflamed names a disease state in a bullet, which can trigger Amazon suppression and treatment as a drug claim.

→ Remove disease terms from title, bullets, A+ content, and backend keywords.

Standard: Disease keyword in Amazon title/bullets

High

“Users felt the difference within 7 days.”

A time-to-result claim needs finished-product trial data supporting the exact 7-day timeframe.

→ Remove unless a trial supports the exact timeframe.

Standard: works in a set number of days

High

“In a study, DemoNerve users reported a significant drop in pain scores after 7 days.”

A study reporting lower pain scores reads as a treatment result, the kind of study run in people with neuropathy.

→ Cite studies in healthy populations, or remove the citation.

Standard: Ingredient study on a disease population

Critical

“DemoNerve goes after the root cause of nerve pain in the feet, hands, arms, legs, head and neck.”

Claiming to target the cause of pain is an explicit drug function claim.

→ Replace with “Provides B vitamins that support normal nerve function.”

Standard: analgesic / pain reliever / relieves pain

Critical

“Relief support for burning, tingling and numbness.”

Burning, tingling and numbness are symptoms of neuropathy, and addressing them is a drug claim.

→ Remove.

Standard: relieves symptoms of

Critical

“Nourishes damaged, struggling nerves.”

'Damaged nerves' names a pathological state rather than a normal structure/function.

→ Replace with “Supports healthy nerve function.”

Standard: Disease keyword in Amazon title/bullets

Critical

“Alpha lipoic acid shields your nerves from damage.”

Shielding nerves from damage is a disease prevention claim.

→ Replace with “Alpha lipoic acid is an antioxidant that supports healthy nerve cells.”

Standard: prevents

Your claims agent

It never approves, signs or certifies an answer, and it never edits a listing. An answer is an AI draft until the pharmacist signs it.

Paste a line you want to publish. It is ruled against the same 109 standards as your audit, with the rule cited, and failing lines come back with allowed wording, checked again. Answers usually arrive within a few minutes. Send any answer to the pharmacist and it comes back signed, reworded or declined with a reason.

Answers come from AI software. The pharmacist does not review an answer unless you ask for that in your file.

Done on your file, by stage

Each entry says which stage did it and when. Nothing here was published or changed on your listing, page, ad or store.

Ruling · automation

Rules each line of the text that was read against the published standards, quoting the line and citing the rule.

Ruling · 3 Nov, 19:20Letter ruled: 8 findings Open Your warning letter →

Licensed pharmacist · a person

Reviews the findings and signs the file. Only the pharmacist signs.

Licensed pharmacist · 4 Nov, 19:20Signed report delivered Open Signed report →
Licensed pharmacist · 4 Nov, 19:203 signed lines saved to Claim memory Open Claim memory →

This file, oldest first

You asked · Nov 5, 13:20 · answered Nov 5, 13:22

AllowedAI draft, not yet signed

“Our ashwagandha gummies support restful sleep”

Line foundNo line flagged

Rule and sourceNo rule raised

Allowed wordingYour line as written

PharmacistNot yet signed

Allowed

No findings · 109 standards

Keep the FDA disclaimer wherever this runs as a structure/function claim.

This answer comes from AI software. The pharmacist does not review it unless you ask for that in your file.

Your claims agent · unsigned

You asked · Nov 5, 16:20 · answered Nov 5, 16:22

Needs changesPharmacist-reviewed

“Can we say our formula balances cortisol and reduces anxiety?”

Line foundtreats anxiety / for anxiety; balances hormones

Rule and sourceCV-NC-01, CV-ID-0821 CFR 101.93(g)

Allowed wording3 options, each checked again

PharmacistSigned Nov 5

Critical

treats anxiety / for anxiety · CV-NC-01

Anxiety is a named condition. Claiming to reduce it is a disease claim.

Rule source: 21 CFR 101.93(g) · FDCA s.201(g)(1)(B)

High

balances hormones · CV-ID-08

"Balance" implies correcting a pathological imbalance.

Rule source: 21 CFR 101.93(g)

This phrase is flagged at 6 of 109 Immune brands we ruled. Immune data →

Three options, up to the strongest the standard allows, each checked again

Safest

Helps the body adapt to occasional stress.

Amazon listing · Label (with the FDA disclaimer) · Website · Ads · Email · Checked again: no findings

Balanced

Promotes a sense of calm and helps the body adapt to occasional stress.

Amazon listing · Label (with the FDA disclaimer) · Website · Ads · Email · Checked again: no findings

Strongest allowed: the furthest this claim can go and still pass

Supports healthy cortisol levels already within the normal range and promotes a sense of calm.

Amazon listing · Label (with the FDA disclaimer) · Website · Ads · Email · Checked again: no findings

Keeps: cortisol

This answer came from AI software and was then reviewed by the pharmacist.

Signed by the licensed pharmacist · Nov 5Reviewer note: Use the safest option on the label.

Findings and fixes

8 findings quoted in the letter, each with its corrective action.

CriticalCV-IC-02

“DemoNerve Nerve Support, 60 capsules: delivers key nutrients to damaged and inflamed nerves.”

→ Rename the product title, since the title itself makes the treatment claim.

The product title itself promises help for damaged and inflamed nerves, so every place the title runs carries a treatment claim. Can lead to: FDA: a warning letter treating it as a drug claim.

Rule source: 21 CFR 101.93(g)

This phrase is flagged at 3 of 109 Immune brands we ruled. Immune data →

CriticalCV-PP-08

“Formulated for damaged and inflamed nerves.”

→ Remove disease terms from title, bullets, A+ content, and backend keywords.

Describing nerves as damaged and inflamed names a disease state in a bullet, which can trigger Amazon suppression and treatment as a drug claim. Can lead to: FDA: a warning letter treating it as a drug claim, Amazon: listing suppression.

Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)

This phrase is flagged at 13 of 109 Immune brands we ruled. Immune data →

HighCV-SB-03

“Users felt the difference within 7 days.”

→ Remove unless a trial supports the exact timeframe.

A time-to-result claim needs finished-product trial data supporting the exact 7-day timeframe. Can lead to: FTC: a demand for the substantiation, Competition Bureau: a misleading-advertising complaint, Ad Standards Canada: a complaint, Walmart: listing removal.

Rule source: FTC Act s.5(a), 15 U.S.C. 45(a)

This phrase is flagged at 5 of 109 Immune brands we ruled. Immune data →

HighCV-IC-03

“In a study, DemoNerve users reported a significant drop in pain scores after 7 days.”

→ Cite studies in healthy populations, or remove the citation.

A study reporting lower pain scores reads as a treatment result, the kind of study run in people with neuropathy. Can lead to: FDA: a warning letter treating it as a drug claim, FTC: a demand for the substantiation.

Rule source: FTC Health Products Compliance Guidance (December 2022)

CriticalCV-ID-05

“DemoNerve goes after the root cause of nerve pain in the feet, hands, arms, legs, head and neck.”

→ “Provides B vitamins that support normal nerve function.”

Keeps: nerve

Claiming to target the cause of pain is an explicit drug function claim. Can lead to: FDA: a warning letter treating it as a drug claim.

Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)

This phrase is flagged at 2 of 109 Immune brands we ruled. Immune data →

CriticalCV-DV-09

“Relief support for burning, tingling and numbness.”

→ Remove.

Burning, tingling and numbness are symptoms of neuropathy, and addressing them is a drug claim. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.

Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)

This phrase is flagged at 6 of 109 Immune brands we ruled. Immune data →

CriticalCV-PP-08

“Nourishes damaged, struggling nerves.”

→ “Supports healthy nerve function.”

Keeps: nerves

'Damaged nerves' names a pathological state rather than a normal structure/function. Can lead to: FDA: a warning letter treating it as a drug claim, Amazon: listing suppression.

Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)

This phrase is flagged at 13 of 109 Immune brands we ruled. Immune data →

CriticalCV-DV-03

“Alpha lipoic acid shields your nerves from damage.”

→ “Alpha lipoic acid is an antioxidant that supports healthy nerve cells.”

Keeps: alpha, lipoic, acid, nerves

Shielding nerves from damage is a disease prevention claim. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.

Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)

This phrase is flagged at 8 of 109 Immune brands we ruled. Immune data →

Claims section for counsel

The claims review and replacement wording, signed by the pharmacist, for your counsel to use in the response.

Claims section for counselCurrent

client_report_demo_brand_warning_letter.pdf · signed Nov 4, 2026 Open the sample →

Finished copy

Not performed: no listing copy on this file was replaced field by field. Every finding with the wording to use is in Findings and fixes.

Claim memory

Every line a pharmacist has signed for Demo brand: wording that already passed review, kept here to reuse across your listings and ads. The next ad, variant or marketplace can start from a line that passed.

Copy any line. Structure/function lines carry the FDA disclaimer wherever they run.

Provides B vitamins that support normal nerve function.

Listing · Label (with the FDA disclaimer) · Website · Ads · Email

Signed

Supports healthy nerve function.

Listing · Label (with the FDA disclaimer) · Website · Ads · Email

Signed

Alpha lipoic acid is an antioxidant that supports healthy nerve cells.

Listing · Label (with the FDA disclaimer) · Website · Ads · Email

Signed

AI answers

Included in the audit when available. What 5 assistants tell a shopper who asks about Demo brand: ChatGPT, Claude, Gemini, Perplexity, Grok. Amazon says Alexa for Shopping (formerly Rufus) answers from listing details, reviews and Q&A, so the wording in Finished copy is what it has to read.

HighFixed

“ChatGPT: "It is known to boost immunity and help fight off colds."”

Repeated a cold claim your audit removed, drawn from an old product page that was still live. The page was taken down and ChatGPT re-tested on Nov 2.

→ Now: “It is marketed as supporting healthy immune function.”

MediumFlagged

“Perplexity: "Reviewers say it is clinically proven."”

Drawn from a customer review, not your copy. It is not a claim you made, so it is flagged for you to watch rather than fixed.

Check it yourself, same question: ChatGPT · Claude · Gemini (opens the app, paste the question) · Perplexity · Grok

Category rank

Riskier than 94% of Immune best-sellers

#11 of 194, 1 is riskiest. Fix the findings in this file and the re-scan shows the move, against the same best sellers.

Ranked against the 194 best sellers you compete with in Immune, by what a platform can act on in the copy. It is a risk rank, not a sales rank. 6 of them carry nothing a platform can act on.

DEMO-LISTING · Immune support supplement, 90 capsules

Lower riskEvery Immune best-seller we ruled, by risk scoreHigher risk

Safer than yoursRiskier than yours

Scanned 2026-10-27

#11

Riskiest 6% of the category

Label and licence checks

We check your listing against your own label on file with the NIH, rule the claims printed on it, and for Canadian products compare your copy with what your Health Canada licence allows. For a Canadian launch, the licence states the claims the product may make, so copy that matches it starts from wording the licence already allows.

US label check: matched your label on file with the NIH Dietary Supplement Label Database. Every amount on the listing appears on the Supplement Facts panel. Front and back panel claims ruled with the audit.

Canada licence check: not run. No NPN was supplied for this product. With one, every sentence of your copy is compared with the purpose your Health Canada licence allows.

Not run

Billing

No payments yet. Your file opened .

Next: a payment shows here the day it clears.

Change history

Every step on your file, dated. Every ruling in it carries the standards version it was made under.

Nov 5PharmacistAnswer signed by the pharmacist

Nov 5YouAsked about: “Can we say our formula balances cortisol…”

Nov 5YouAsked about: “Our ashwagandha gummies support restful sleep”

Nov 4PharmacistClaims section signed by the pharmacist and sent to counsel

Nov 3EngineEvery quoted claim ruled, and other copy swept for the same claims

Nov 2YouUploaded warning_letter.pdf

Nov 2YouFile opened